Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pulmo BioTech has announced that its subsidiary, PulmoScience has completed the bio-distribution studies on its DFH-12 product candidate for the PulmoBind technology of molecular imaging of the vascular system of the lungs.
Subscribe to our email newsletter
The in- vivo studies have shown that the molecule is predominantly retained in the lungs 30 minutes after injection with only minor retention in the liver and heart.
Further bio-distribution studies have also shown that after 240 minutes the majority of the injected molecules have been eliminated through the kidneys and bladder.